# Hycroft Mining Holding Corp: financial statements, quarterly

HYMC · Nasdaq · CIK 1718405 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hymc.md) · [Financials](/companies/hymc/financials.md) · [Filings](/companies/hymc/filings.md) · [Insiders](/companies/hymc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hymc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0 d](/filings/0001718405-24-000012.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | [0.0 d](/filings/0001718405-24-000012.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [4.7 d](/filings/0001718405-25-000006.md) | [4.9](/filings/0001718405-25-000016.md) | [5.1](/filings/0001718405-25-000026.md) | [4.7](/filings/0001718405-25-000033.md) | [4.9 d](/filings/0001718405-26-000009.md) | [3.0](/filings/0001718405-26-000014.md) | [2.3](/filings/0001718405-26-000020.md) | [4.0](/filings/0001718405-26-000030.md) | [5.5 d](/filings/0001718405-26-000009.md) | [9.7](/filings/0001718405-26-000014.md) | [8.6](/filings/0001718405-26-000020.md) | [8.3](/filings/0001718405-26-000030.md) |
| Operating income | $m | [(8.3) d](/filings/0001718405-25-000006.md) | [(11.9)](/filings/0001718405-25-000016.md) | [(10.5)](/filings/0001718405-25-000026.md) | [(11.7)](/filings/0001718405-25-000033.md) | [(9.6) d](/filings/0001718405-26-000009.md) | [(9.2)](/filings/0001718405-26-000014.md) | [(9.3)](/filings/0001718405-26-000020.md) | [(7.3)](/filings/0001718405-26-000030.md) | [(18.7) d](/filings/0001718405-26-000009.md) | [(50.1)](/filings/0001718405-26-000014.md) | [(22.5)](/filings/0001718405-26-000020.md) | [(28.2)](/filings/0001718405-26-000030.md) |
| Income tax | $m | [0.0 d](/filings/0001718405-25-000006.md) | [0.0](/filings/0001718405-25-000016.md) | [0.0 d](/filings/0001718405-25-000026.md) | [0.0](/filings/0001718405-24-000029.md) | [0.0 d](/filings/0001718405-26-000009.md) | [0.0](/filings/0001718405-26-000014.md) | [0.0](/filings/0001718405-26-000020.md) | [0.0](/filings/0001718405-26-000030.md) | [0.0 d](/filings/0001718405-26-000009.md) | [0.0](/filings/0001718405-26-000014.md) | [0.0](/filings/0001718405-26-000020.md) | [0.0](/filings/0001718405-26-000030.md) |
| Net income | $m | [(11.5) d](/filings/0001718405-25-000006.md) | [(20.7)](/filings/0001718405-25-000033.md) | [(13.2)](/filings/0001718405-25-000033.md) | [(14.2)](/filings/0001718405-25-000033.md) | [(12.7) d](/filings/0001718405-26-000009.md) | [(11.8)](/filings/0001718405-26-000030.md) | [(11.7)](/filings/0001718405-26-000030.md) | [(9.4)](/filings/0001718405-26-000030.md) | [(7.8) d](/filings/0001718405-26-000009.md) | [(48.3)](/filings/0001718405-26-000030.md) | [(20.8)](/filings/0001718405-26-000030.md) | [(26.1)](/filings/0001718405-26-000030.md) |
| Diluted EPS | $ per share | not reported | [(1.00)](/filings/0001718405-25-000016.md) | [(0.57)](/filings/0001718405-25-000026.md) | [(0.59)](/filings/0001718405-25-000033.md) | not reported | [(0.47)](/filings/0001718405-26-000014.md) | [(0.43)](/filings/0001718405-26-000020.md) | [(0.22)](/filings/0001718405-26-000030.md) | not reported | [(0.54)](/filings/0001718405-26-000014.md) | [(0.23)](/filings/0001718405-26-000020.md) | [(0.28)](/filings/0001718405-26-000030.md) |
| Basic EPS | $ per share | not reported | [(1.00)](/filings/0001718405-25-000016.md) | [(0.57)](/filings/0001718405-25-000026.md) | [(0.59)](/filings/0001718405-25-000033.md) | not reported | [(0.47)](/filings/0001718405-26-000014.md) | [(0.43)](/filings/0001718405-26-000020.md) | [(0.22)](/filings/0001718405-26-000030.md) | not reported | [(0.54)](/filings/0001718405-26-000014.md) | [(0.23)](/filings/0001718405-26-000020.md) | [(0.28)](/filings/0001718405-26-000030.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [106](/filings/0001718405-25-000006.md) | [57.6](/filings/0001718405-25-000016.md) | [58.5](/filings/0001718405-25-000026.md) | [55.8](/filings/0001718405-25-000033.md) | [49.6](/filings/0001718405-26-000009.md) | [39.7](/filings/0001718405-26-000014.md) | [68.8](/filings/0001718405-26-000020.md) | [139](/filings/0001718405-26-000030.md) | [182](/filings/0001718405-26-000030.md) | [189](/filings/0001718405-26-000014.md) | [221](/filings/0001718405-26-000020.md) | [211](/filings/0001718405-26-000030.md) |
| Current assets | $m | [114](/filings/0001718405-25-000006.md) | [65.5](/filings/0001718405-24-000020.md) | [67.2](/filings/0001718405-24-000025.md) | [64.1](/filings/0001718405-24-000029.md) | [54.6](/filings/0001718405-26-000009.md) | [44.0](/filings/0001718405-25-000016.md) | [74.8](/filings/0001718405-25-000026.md) | [145](/filings/0001718405-25-000033.md) | [187](/filings/0001718405-26-000030.md) | [194](/filings/0001718405-26-000014.md) | [226](/filings/0001718405-26-000020.md) | [217](/filings/0001718405-26-000030.md) |
| Total assets | $m | [202](/filings/0001718405-25-000006.md) | [153](/filings/0001718405-24-000020.md) | [155](/filings/0001718405-24-000025.md) | [149](/filings/0001718405-24-000029.md) | [140](/filings/0001718405-26-000009.md) | [129](/filings/0001718405-25-000016.md) | [162](/filings/0001718405-25-000026.md) | [231](/filings/0001718405-25-000033.md) | [263](/filings/0001718405-26-000030.md) | [270](/filings/0001718405-26-000014.md) | [293](/filings/0001718405-26-000020.md) | [285](/filings/0001718405-26-000030.md) |
| Current liabilities | $m | [11.7](/filings/0001718405-25-000006.md) | [6.0](/filings/0001718405-24-000020.md) | [9.2](/filings/0001718405-24-000025.md) | [9.6](/filings/0001718405-24-000029.md) | [5.8](/filings/0001718405-26-000009.md) | [2.7](/filings/0001718405-25-000016.md) | [2.9](/filings/0001718405-25-000026.md) | [7.6](/filings/0001718405-25-000033.md) | [7.7](/filings/0001718405-26-000030.md) | [4.2](/filings/0001718405-26-000014.md) | [5.8](/filings/0001718405-26-000020.md) | [16.0](/filings/0001718405-26-000030.md) |
| Total liabilities | $m | [189](/filings/0001718405-25-000006.md) | [159](/filings/0001718405-24-000020.md) | [165](/filings/0001718405-24-000025.md) | [172](/filings/0001718405-24-000029.md) | [174](/filings/0001718405-26-000009.md) | [174](/filings/0001718405-25-000016.md) | [177](/filings/0001718405-25-000026.md) | [183](/filings/0001718405-25-000033.md) | [49.3](/filings/0001718405-26-000030.md) | [46.1](/filings/0001718405-26-000014.md) | [42.2](/filings/0001718405-26-000020.md) | [47.0](/filings/0001718405-26-000030.md) |
| Long-term debt | $m | [143](/filings/0001718405-25-000006.md) | [116](/filings/0001718405-24-000020.md) | [119](/filings/0001718405-24-000025.md) | [122](/filings/0001718405-24-000029.md) | [125](/filings/0001718405-26-000009.md) | [128](/filings/0001718405-25-000016.md) | [131](/filings/0001718405-25-000026.md) | [134](/filings/0001718405-25-000033.md) | [0.0](/filings/0001718405-26-000009.md) | not reported | not reported | not reported |
| Current portion of debt | $m | [2.3](/filings/0001718405-25-000006.md) | [0.1](/filings/0001718405-24-000020.md) | [0.1](/filings/0001718405-24-000025.md) | [0.1](/filings/0001718405-24-000029.md) | [0.1](/filings/0001718405-26-000009.md) | [0.0](/filings/0001718405-25-000016.md) | [0.0](/filings/0001718405-25-000026.md) | [0.0](/filings/0001718405-25-000033.md) | [0.0](/filings/0001718405-26-000009.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [12.7](/filings/0001718405-26-000009.md) | [(6.3)](/filings/0001718405-25-000033.md) | [(9.7)](/filings/0001718405-25-000033.md) | [(23.1)](/filings/0001718405-25-000033.md) | [(33.4)](/filings/0001718405-26-000030.md) | [(44.5)](/filings/0001718405-26-000030.md) | [(15.3)](/filings/0001718405-26-000030.md) | [47.5](/filings/0001718405-26-000030.md) | [214](/filings/0001718405-26-000030.md) | [224](/filings/0001718405-26-000030.md) | [251](/filings/0001718405-26-000030.md) | [238](/filings/0001718405-26-000030.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(9.5) d](/filings/0001718405-25-000006.md) | [(11.7)](/filings/0001718405-25-000016.md) | [(8.6) d](/filings/0001718405-25-000026.md) | [(7.5) d](/filings/0001718405-25-000033.md) | [(8.1) d](/filings/0001718405-26-000009.md) | [(9.7)](/filings/0001718405-26-000014.md) | [(9.0) d](/filings/0001718405-26-000020.md) | [(3.4) d](/filings/0001718405-26-000030.md) | [(60.7) d](/filings/0001718405-26-000009.md) | [(31.3)](/filings/0001718405-26-000014.md) | [(12.7) d](/filings/0001718405-26-000020.md) | [(7.7) d](/filings/0001718405-26-000030.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001718405-25-000006.md) | [0.0](/filings/0001718405-25-000016.md) | [0.4 d](/filings/0001718405-25-000026.md) | [0.5 d](/filings/0001718405-25-000033.md) | [0.3 d](/filings/0001718405-26-000009.md) | [0.2](/filings/0001718405-26-000014.md) | [0.2 d](/filings/0001718405-26-000020.md) | [0.1 d](/filings/0001718405-26-000030.md) | [0.1 d](/filings/0001718405-26-000009.md) | [0.6](/filings/0001718405-26-000014.md) | [0.3 d](/filings/0001718405-26-000020.md) | [0.6 d](/filings/0001718405-26-000030.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.0](/filings/0001718405-24-000020.md) | [20.1](/filings/0001718405-24-000025.md) | [20.2](/filings/0001718405-24-000029.md) | [20.8](/filings/0001718405-25-000016.md) | [23.0](/filings/0001718405-25-000026.md) | [24.1](/filings/0001718405-25-000033.md) | [24.9](/filings/0001718405-26-000014.md) | [27.6](/filings/0001718405-26-000020.md) | [42.5](/filings/0001718405-26-000030.md) | [89.7](/filings/0001718405-26-000014.md) | [91.5](/filings/0001718405-26-000020.md) | [93.2](/filings/0001718405-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 93,183,554 at 2026-10-26, from the cover of the [10-Q filed 2026-10-27](/filings/0001718405-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 06:15 ET. No prices; not investment advice.